Cargando…
Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059357/ https://www.ncbi.nlm.nih.gov/pubmed/35501773 http://dx.doi.org/10.1186/s12885-022-09517-0 |
| _version_ | 1784698294393372672 |
|---|---|
| author | Lai, Jinzhi Xu, Tianwen Yang, Hainan |
| author_facet | Lai, Jinzhi Xu, Tianwen Yang, Hainan |
| author_sort | Lai, Jinzhi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9059357 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90593572022-05-03 Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma Lai, Jinzhi Xu, Tianwen Yang, Hainan BMC Cancer Correction BioMed Central 2022-05-02 /pmc/articles/PMC9059357/ /pubmed/35501773 http://dx.doi.org/10.1186/s12885-022-09517-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Lai, Jinzhi Xu, Tianwen Yang, Hainan Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma |
| title | Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma |
| title_full | Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma |
| title_fullStr | Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma |
| title_full_unstemmed | Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma |
| title_short | Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma |
| title_sort | correction: protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059357/ https://www.ncbi.nlm.nih.gov/pubmed/35501773 http://dx.doi.org/10.1186/s12885-022-09517-0 |
| work_keys_str_mv | AT laijinzhi correctionproteinbasedprognosticsignatureforpredictingthesurvivalandimmunotherapeuticefficiencyofendometrialcarcinoma AT xutianwen correctionproteinbasedprognosticsignatureforpredictingthesurvivalandimmunotherapeuticefficiencyofendometrialcarcinoma AT yanghainan correctionproteinbasedprognosticsignatureforpredictingthesurvivalandimmunotherapeuticefficiencyofendometrialcarcinoma |